NCT03629496

Brief Summary

This research study aims to develop an arts-based intervention for patients with end-stage kidney disease (ESKD) that can be implemented during haemodialysis sessions, and to assess the feasibility of a randomised controlled trial (RCT). Haemodialysis is the most common treatment for patients with ESKD; it involves attending hospital three times a week for a period of four hours each time, during that time the patient is connected to a dialysing unit that drains and filters their blood, performing the role of the damaged kidneys. Patients with ESKD receiving haemodialysis report low quality of life (QoL) and poor mental health. Arts-based interventions have been used in a variety of different settings to improve both QoL and mental health, but there's a lack of research assessing their effectiveness in patients with ESKD receiving haemodialysis. This study will develop an arts-based intervention by reviewing the existing literature and forming an advisory group consisting of patients, healthcare staff, artists and academics. Once developed a feasibility RCT will be conducted on a haemodialysis unit. The feasibility RCT will involve establishing the recruitment, participation and retention rates of patients who are eligible for inclusion. A process evaluation will be conducted alongside the feasibility trial; this will involve interviews with patients and focus groups with staff to explore experiences of the intervention. Finally a feasibility economic evaluation will be conducted to explore methods for a cost-effectiveness analysis within an RCT. The hope is this study will contribute to a future RCT that will evaluate the impact of arts-based interventions on the QoL and mental health of patients receiving haemodialysis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2018

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 23, 2018

Completed
22 days until next milestone

First Posted

Study publicly available on registry

August 14, 2018

Completed
20 days until next milestone

Study Start

First participant enrolled

September 3, 2018

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 21, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 21, 2019

Completed
Last Updated

March 20, 2019

Status Verified

March 1, 2019

Enrollment Period

5 months

First QC Date

July 23, 2018

Last Update Submit

March 18, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Recruitment and retention rates

    Amount of participants recruited into the study, and the amount of the participants who remain in the study until its conclusion.

    Seven months

Secondary Outcomes (8)

  • Completion rate of Kidney Disease Quality of Life Short Form 36

    Data collection at baseline, 3 weeks, 6 weeks and 3 months per participant

  • Proportion of missing data from Kidney Disease Quality of Life Short Form 36

    Data collection at baseline, 3 weeks, 6 weeks and 3 months per participant

  • Complete rate of missing data from Hospital Anxiety and Depression Scale

    Data collection at baseline, 3 weeks, 6 weeks and 3 months per participant.

  • Proportion of missing data from Hospital Anxiety and Depression Scale

    Data collection at baseline, 3 weeks, 6 weeks and 3 months per participant.

  • Completion rate of EuroQuol 5d 5l (EQ-5d-5l)

    Data collection at baseline, 3 weeks, 6 weeks and 3 months per participant

  • +3 more secondary outcomes

Study Arms (2)

Arts-based intervention

EXPERIMENTAL

Participants will participate in 6x1 hourly art sessions over a period of 3 weeks while they receive their haemodialysis treatment. This will involve 1:1 facilitation with a student and will involve visual arts including sketching, water colour painting and pen and ink, and creative writing activities. Participants will be provided with their own art supplies for infection control purposes and these will be kept on the unit in between sessions. Participants will have an option of displaying completed work in the reception area of the unit during their sessions.

Other: Arts-based intervention

Control

NO INTERVENTION

Participants will receive usual care during their haemodialysis sessions and will be asked not to engage in any creative writing or visual arts during their haemodialysis sessions for the duration of the study. Once data collection has been completed the participants in the control group will receive art supplies and a single facilitated session on haemodialysis for the purpose of equity.

Interventions

6x1 hourly facilitated art sessions during haemodialysis. Participants will be provided with an option of visual art or creative writing, the artistic materials used will include graphite pencils, colouring pencils, water colour paints and graphic pens. Participants will be provided with their own art supplies for infection control purposes. During each session participants will be allowed to self-select a subject matter or be provided with binary prompts to facilitate decision making. Participants will also have an option of displaying completed work in the reception area of the unit during their haemodialysis sessions.

Arts-based intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Over 18
  • Receiving haemodialysis
  • Physically and cognitively able to consent and take part in art activities

You may not qualify if:

  • Under 18
  • Unable to read, write or speak English.
  • Physically and cognitively unable to consent and take part in art activities.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Antrim Area Hospital Renal Unit

Antrim, BT41 2RL, United Kingdom

Location

Related Publications (2)

  • Carswell C, Reid J, Walsh I, Johnston W, McAneney H, Mullan R, Lee JB, Nelson H, Matthews M, Weatherup E, Spencer A, Michelo J, Quail A, Kielty G, Mackenzie A, Elliott J, Arbuckle N, Wilson A, Noble H. A mixed-methods feasibility study of an arts-based intervention for patients receiving maintenance haemodialysis. BMC Nephrol. 2020 Nov 19;21(1):497. doi: 10.1186/s12882-020-02162-4.

  • Carswell C, Reid J, Walsh I, McAneney H, Noble H. Implementing an arts-based intervention for patients with end-stage kidney disease whilst receiving haemodialysis: a feasibility study protocol. Pilot Feasibility Stud. 2019 Jan 5;5:1. doi: 10.1186/s40814-018-0389-y. eCollection 2019.

MeSH Terms

Conditions

Disease

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Helen Noble, PhD

    Queen's University, Belfast

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: Feasibility randomised controlled trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chief Investigator, Lecturer

Study Record Dates

First Submitted

July 23, 2018

First Posted

August 14, 2018

Study Start

September 3, 2018

Primary Completion

January 21, 2019

Study Completion

January 21, 2019

Last Updated

March 20, 2019

Record last verified: 2019-03

Locations